{ "name": "Arrowhead Pharmaceuticals, Inc.", "slug": "arrowhead-pharmaceuticals-inc", "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.", "status": "complete", "updated_at": "2026-08-06T07:14:38Z", "nasdaq_status": "retrieved", "latest_market": "2026-08-05: stängning 86.91, volym 1703440", "mfn_status": "skipped", "mfn_count": 0, "nasdaq_reports_status": "skipped", "reports": { "available": false, "url": "/company/arrowhead-pharmaceuticals-inc/reports", "count": 0, "nasdaq_count": 0, "mfn_fallback_count": 0, "items": [] }, "report_count": 0, "nasdaq_report_count": 0, "mfn_fallback_count": 0, "sec_status": "retrieved", "sec_count": 52, "fi_status": "skipped", "fi_summary": {}, "warnings": [], "source_identity": { "nasdaq_reports": null, "mfn": null, "sec": { "status": "resolved", "method": "explicit_ticker", "expected_name": "Arrowhead Pharmaceuticals, Inc.", "ticker": "ARWR", "title": "ARROWHEAD PHARMACEUTICALS, INC.", "cik": "0000879407", "match_score": 100.0 }, "nasdaq": null, "finansinspektionen": null }, "documents": [ { "doc_id": "sec-edgar-8-k-2026-08-04-arwr-20260804-htm", "title": "8-K – 2026-08-04 – arwr-20260804.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000058/arwr-20260804.htm", "date": "2026-08-04", "period": "2026-08-04", "form_type": "8-K", "report_key": null, "filename": "arwr-20260804.htm", "text_chars": 3421, "sha256": "0eea8a14d59123abf80ee6d30e02e352ef39cfc0825449fae8108cc77e10939b", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-08-04-arwr-20260804-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-08-04-arwr-20260804-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-08-04-arwr-20260804-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-08-04-arwr-20260804-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-08-04-arwr-20260804-htm/part-001.html", "chars": 3421 } ] }, { "doc_id": "sec-edgar-10-q-2026-08-04-arwr-20260630-htm", "title": "10-Q – 2026-08-04 – arwr-20260630.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000057/arwr-20260630.htm", "date": "2026-08-04", "period": "2026-06-30", "form_type": "10-Q", "report_key": null, "filename": "arwr-20260630.htm", "text_chars": 199044, "sha256": "2c3003dda1eb0673f1b036bee2ba8aee3af7decefeb3a4b95eeb2dd9a69cee66", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-08-04-arwr-20260630-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-08-04-arwr-20260630-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-08-04-arwr-20260630-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-08-04-arwr-20260630-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-08-04-arwr-20260630-htm/part-001.html", "chars": 179250 }, { "number": 2, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-08-04-arwr-20260630-htm/part-002.html", "chars": 19792 } ] }, { "doc_id": "sec-edgar-8-k-2026-06-16-arwr-20260612-htm", "title": "8-K – 2026-06-16 – arwr-20260612.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000050/arwr-20260612.htm", "date": "2026-06-16", "period": "2026-06-12", "form_type": "8-K", "report_key": null, "filename": "arwr-20260612.htm", "text_chars": 5348, "sha256": "453e24903b4c2f2ac2d5e0fc8f546239c224dd66a460e001cca70466f649b890", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-06-16-arwr-20260612-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-06-16-arwr-20260612-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-06-16-arwr-20260612-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-06-16-arwr-20260612-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-06-16-arwr-20260612-htm/part-001.html", "chars": 5348 } ] }, { "doc_id": "sec-edgar-8-k-2026-05-07-arwr-20260507-htm", "title": "8-K – 2026-05-07 – arwr-20260507.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000045/arwr-20260507.htm", "date": "2026-05-07", "period": "2026-05-07", "form_type": "8-K", "report_key": null, "filename": "arwr-20260507.htm", "text_chars": 3426, "sha256": "4496fe8a2f27bddc39172d2a8abf44ab054ffe3026253c9dbb8ab5787f2d8450", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-05-07-arwr-20260507-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-05-07-arwr-20260507-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-05-07-arwr-20260507-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-05-07-arwr-20260507-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-05-07-arwr-20260507-htm/part-001.html", "chars": 3426 } ] }, { "doc_id": "sec-edgar-10-q-2026-05-07-arwr-20260331-htm", "title": "10-Q – 2026-05-07 – arwr-20260331.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000047/arwr-20260331.htm", "date": "2026-05-07", "period": "2026-03-31", "form_type": "10-Q", "report_key": null, "filename": "arwr-20260331.htm", "text_chars": 188989, "sha256": "7b7ec9ae4ddc9189d6660c83c5248c8501f3a5a7dfcfa7c83e580f01b8b3396d", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-05-07-arwr-20260331-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-05-07-arwr-20260331-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-05-07-arwr-20260331-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-05-07-arwr-20260331-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-05-07-arwr-20260331-htm/part-001.html", "chars": 178079 }, { "number": 2, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-05-07-arwr-20260331-htm/part-002.html", "chars": 10907 } ] }, { "doc_id": "sec-edgar-8-k-2026-03-20-arwr-20260319-htm", "title": "8-K – 2026-03-20 – arwr-20260319.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000037/arwr-20260319.htm", "date": "2026-03-20", "period": "2026-03-19", "form_type": "8-K", "report_key": null, "filename": "arwr-20260319.htm", "text_chars": 4702, "sha256": "8c5de90ad630e7aab28b8018c2cc8246689ef440e0376ebf3af2e6c7b2f97134", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-03-20-arwr-20260319-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-03-20-arwr-20260319-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-03-20-arwr-20260319-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-03-20-arwr-20260319-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-03-20-arwr-20260319-htm/part-001.html", "chars": 4702 } ] }, { "doc_id": "sec-edgar-8-k-2026-02-05-arwr-20260205-htm", "title": "8-K – 2026-02-05 – arwr-20260205.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000033/arwr-20260205.htm", "date": "2026-02-05", "period": "2026-02-05", "form_type": "8-K", "report_key": null, "filename": "arwr-20260205.htm", "text_chars": 3449, "sha256": "c4056ea46eccb795ba0ccb1de1394956b0ab09bd327e50e9f70953ed5f569483", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-02-05-arwr-20260205-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-02-05-arwr-20260205-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-02-05-arwr-20260205-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-02-05-arwr-20260205-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-02-05-arwr-20260205-htm/part-001.html", "chars": 3449 } ] }, { "doc_id": "sec-edgar-10-q-2026-02-05-arwr-20251231-htm", "title": "10-Q – 2026-02-05 – arwr-20251231.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000034/arwr-20251231.htm", "date": "2026-02-05", "period": "2025-12-31", "form_type": "10-Q", "report_key": null, "filename": "arwr-20251231.htm", "text_chars": 167817, "sha256": "474f37aff11baea3faf6f7fc7e3fa89ae416dd7d65fde23e1220483bbcc3e6f1", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-02-05-arwr-20251231-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-02-05-arwr-20251231-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-02-05-arwr-20251231-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-02-05-arwr-20251231-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2026-02-05-arwr-20251231-htm/part-001.html", "chars": 167817 } ] }, { "doc_id": "sec-edgar-8-k-2026-01-12-d19865d8k-htm", "title": "8-K – 2026-01-12 – d19865d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000119312526010582/d19865d8k.htm", "date": "2026-01-12", "period": "2026-01-12", "form_type": "8-K", "report_key": null, "filename": "d19865d8k.htm", "text_chars": 14370, "sha256": "58381c163b3d057e90a552b5986a354de41ee3b315e40969f668831cfd8c043a", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-12-d19865d8k-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-12-d19865d8k-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-12-d19865d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-12-d19865d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-12-d19865d8k-htm/part-001.html", "chars": 14370 } ] }, { "doc_id": "sec-edgar-8-k-2026-01-09-d94918d8k-htm", "title": "8-K – 2026-01-09 – d94918d8k.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000119312526007971/d94918d8k.htm", "date": "2026-01-09", "period": "2026-01-07", "form_type": "8-K", "report_key": null, "filename": "d94918d8k.htm", "text_chars": 9063, "sha256": "9d169b233d7be2cc8c40666cce36dab12b4b3db439a1bf272c3ea9e4d26c30b5", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-09-d94918d8k-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-09-d94918d8k-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-09-d94918d8k-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-09-d94918d8k-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-09-d94918d8k-htm/part-001.html", "chars": 9063 } ] }, { "doc_id": "sec-edgar-8-k-2026-01-06-arwr-20260106-htm", "title": "8-K – 2026-01-06 – arwr-20260106.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940726000004/arwr-20260106.htm", "date": "2026-01-06", "period": "2026-01-06", "form_type": "8-K", "report_key": null, "filename": "arwr-20260106.htm", "text_chars": 10839, "sha256": "40a063601bbf9c09f8498fca321368cca0a460141a26fb380851b9f1b4760e1d", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-06-arwr-20260106-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-06-arwr-20260106-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-06-arwr-20260106-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-06-arwr-20260106-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2026-01-06-arwr-20260106-htm/part-001.html", "chars": 10839 } ] }, { "doc_id": "sec-edgar-8-k-2025-11-25-arwr-20251125-htm", "title": "8-K – 2025-11-25 – arwr-20251125.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940725000027/arwr-20251125.htm", "date": "2025-11-25", "period": "2025-11-25", "form_type": "8-K", "report_key": null, "filename": "arwr-20251125.htm", "text_chars": 3454, "sha256": "58eb05dab7858f0da4e83283c204c843e1a052a74dfdac2bfd2d9f7674dda3f8", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-25-arwr-20251125-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-25-arwr-20251125-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-25-arwr-20251125-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-25-arwr-20251125-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-25-arwr-20251125-htm/part-001.html", "chars": 3454 } ] }, { "doc_id": "sec-edgar-10-k-2025-11-25-arwr-20250930-htm", "title": "10-K – 2025-11-25 – arwr-20250930.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940725000029/arwr-20250930.htm", "date": "2025-11-25", "period": "2025-09-30", "form_type": "10-K", "report_key": null, "filename": "arwr-20250930.htm", "text_chars": 567210, "sha256": "d5432c4de6735a262952269f6efc8fbacab88c93de8dc6c7ed9e867f6f4890b4", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-11-25-arwr-20250930-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-11-25-arwr-20250930-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-11-25-arwr-20250930-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-11-25-arwr-20250930-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-11-25-arwr-20250930-htm/part-001.html", "chars": 179470 }, { "number": 2, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-11-25-arwr-20250930-htm/part-002.html", "chars": 177082 }, { "number": 3, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-11-25-arwr-20250930-htm/part-003.html", "chars": 177978 }, { "number": 4, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-11-25-arwr-20250930-htm/part-004.html", "chars": 32674 } ] }, { "doc_id": "sec-edgar-8-k-2025-11-18-arwr-20251118-htm", "title": "8-K – 2025-11-18 – arwr-20251118.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940725000019/arwr-20251118.htm", "date": "2025-11-18", "period": "2025-11-18", "form_type": "8-K", "report_key": null, "filename": "arwr-20251118.htm", "text_chars": 3273, "sha256": "c5571526a471d4aad9c83692939cea0113fb7ef9850c1a9b44cf93ac873515e1", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-18-arwr-20251118-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-18-arwr-20251118-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-18-arwr-20251118-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-18-arwr-20251118-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-11-18-arwr-20251118-htm/part-001.html", "chars": 3273 } ] }, { "doc_id": "sec-edgar-10-k-2025-10-10-arwr-20240930-htm", "title": "10-K – 2025-10-10 – arwr-20240930.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940725000013/arwr-20240930.htm", "date": "2025-10-10", "period": "2024-09-30", "form_type": "10-K", "report_key": null, "filename": "arwr-20240930.htm", "text_chars": 141531, "sha256": "f0e53cad7755608c42e625829f40c41c9d5d657beb771481f65d93b82a0711a6", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-10-10-arwr-20240930-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-10-10-arwr-20240930-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-10-10-arwr-20240930-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-10-10-arwr-20240930-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-k-2025-10-10-arwr-20240930-htm/part-001.html", "chars": 141531 } ] }, { "doc_id": "sec-edgar-8-k-2025-09-12-arwr-20250911-htm", "title": "8-K – 2025-09-12 – arwr-20250911.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940725000010/arwr-20250911.htm", "date": "2025-09-12", "period": "2025-09-11", "form_type": "8-K", "report_key": null, "filename": "arwr-20250911.htm", "text_chars": 4916, "sha256": "ee43faa75a7c3ba1e7b0a1425c98ecc64798d49444182b8b029d260e34d1504a", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-12-arwr-20250911-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-12-arwr-20250911-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-12-arwr-20250911-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-12-arwr-20250911-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-12-arwr-20250911-htm/part-001.html", "chars": 4916 } ] }, { "doc_id": "sec-edgar-8-k-2025-09-11-arwr-20250910-htm", "title": "8-K – 2025-09-11 – arwr-20250910.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940725000007/arwr-20250910.htm", "date": "2025-09-11", "period": "2025-09-10", "form_type": "8-K", "report_key": null, "filename": "arwr-20250910.htm", "text_chars": 4915, "sha256": "3cae50a4d3f947304a0729896aab15d0155fbf8434c185ac867ceb79aed0e778", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-11-arwr-20250910-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-11-arwr-20250910-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-11-arwr-20250910-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-11-arwr-20250910-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-11-arwr-20250910-htm/part-001.html", "chars": 4915 } ] }, { "doc_id": "sec-edgar-8-k-2025-09-02-arwr-20250902-htm", "title": "8-K – 2025-09-02 – arwr-20250902.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000087940725000004/arwr-20250902.htm", "date": "2025-09-02", "period": "2025-09-02", "form_type": "8-K", "report_key": null, "filename": "arwr-20250902.htm", "text_chars": 4261, "sha256": "627164f4e1b59338ba56c48d84cd6e0235a631aac80eaa78d5b2a60052bdedc4", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-02-arwr-20250902-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-02-arwr-20250902-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-02-arwr-20250902-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-02-arwr-20250902-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-09-02-arwr-20250902-htm/part-001.html", "chars": 4261 } ] }, { "doc_id": "sec-edgar-8-k-2025-08-07-arwr-20250807-htm", "title": "8-K – 2025-08-07 – arwr-20250807.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000162828025038867/arwr-20250807.htm", "date": "2025-08-07", "period": "2025-08-07", "form_type": "8-K", "report_key": null, "filename": "arwr-20250807.htm", "text_chars": 3439, "sha256": "cb10811de7785cd468a15f66d145096920e532047763b5149e6e8615715e0945", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-08-07-arwr-20250807-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-08-07-arwr-20250807-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-08-07-arwr-20250807-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-08-07-arwr-20250807-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-8-k-2025-08-07-arwr-20250807-htm/part-001.html", "chars": 3439 } ] }, { "doc_id": "sec-edgar-10-q-2025-08-07-arwr-20250630-htm", "title": "10-Q – 2025-08-07 – arwr-20250630.htm", "source": "SEC EDGAR", "source_class": "sec", "source_url": "https://www.sec.gov/Archives/edgar/data/879407/000162828025038858/arwr-20250630.htm", "date": "2025-08-07", "period": "2025-06-30", "form_type": "10-Q", "report_key": null, "filename": "arwr-20250630.htm", "text_chars": 154800, "sha256": "6823eac84568a24d4077d36f9b73fe74fde89f06f82719086ff4057053473d15", "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2025-08-07-arwr-20250630-htm", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2025-08-07-arwr-20250630-htm", "txt_url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2025-08-07-arwr-20250630-htm/fulltext.txt", "absolute_txt_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2025-08-07-arwr-20250630-htm/fulltext.txt", "parts": [ { "number": 1, "url": "/company/arrowhead-pharmaceuticals-inc/documents/sec-edgar-10-q-2025-08-07-arwr-20250630-htm/part-001.html", "chars": 154800 } ] } ], "market_files": [ { "label": "Nasdaq kurshistorik CSV", "url": "/company/arrowhead-pharmaceuticals-inc/market/history.csv", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/market/history.csv" }, { "label": "Nasdaq kurshistorik JSON", "url": "/company/arrowhead-pharmaceuticals-inc/market/history.json", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/market/history.json" }, { "label": "Nasdaq manifest JSON", "url": "/company/arrowhead-pharmaceuticals-inc/market/manifest.json", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/market/manifest.json" }, { "label": "SEC Company Facts JSON", "url": "/company/arrowhead-pharmaceuticals-inc/market/sec-companyfacts.json", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/market/sec-companyfacts.json" }, { "label": "SEC filing-manifest JSON", "url": "/company/arrowhead-pharmaceuticals-inc/market/sec-manifest.json", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/market/sec-manifest.json" }, { "label": "SEC sammanfattning JSON", "url": "/company/arrowhead-pharmaceuticals-inc/market/sec-summary.json", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc/market/sec-summary.json" } ], "sec_facts": { "status": "summarized", "entity_name": "ARROWHEAD PHARMACEUTICALS, INC.", "cik": 879407, "metrics": [ { "label": "Intäkter", "taxonomy": "us-gaap", "concept": "RevenueFromContractWithCustomerExcludingAssessedTax", "description": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label_original": "Revenue from Contract with Customer, Excluding Assessed Tax", "facts": [ { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2025-10-01", "end": "2026-06-30", "filed": "2026-08-04", "value": 413023000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2026-08-04", "value": 572976000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2025-10-01", "end": "2026-03-31", "filed": "2026-05-07", "value": 337770000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2026-05-07", "value": 545209000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-10-01", "end": "2025-12-31", "filed": "2026-02-05", "value": 264033000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2025Q4" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2026-02-05", "value": 2500000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2024Q4" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-10-01", "end": "2025-09-30", "filed": "2025-11-25", "value": 829448000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2025-11-25", "value": 3551000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2022-10-01", "end": "2023-09-30", "filed": "2025-11-25", "value": 240735000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2025-08-07", "value": 572976000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2023-10-01", "end": "2024-06-30", "filed": "2025-08-07", "value": 3551000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2025-05-12", "value": 545209000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2023-10-01", "end": "2024-03-31", "filed": "2025-05-12", "value": 3551000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2025-02-10", "value": 2500000, "unit": "USD", "accession": "0001628280-25-004634", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2023-10-01", "end": "2023-12-31", "filed": "2025-02-10", "value": 3551000, "unit": "USD", "accession": "0001628280-25-004634", "frame": "CY2023Q4" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2024-11-26", "value": 3551000, "unit": "USD", "accession": "0001628280-24-049277", "frame": null } ] }, { "label": "Rörelseresultat", "taxonomy": "us-gaap", "concept": "OperatingIncomeLoss", "description": "The net result for the period of deducting operating expenses from operating revenues.", "label_original": "Operating Income (Loss)", "facts": [ { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2025-10-01", "end": "2026-06-30", "filed": "2026-08-04", "value": -270544000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2026-08-04", "value": 54240000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2025-10-01", "end": "2026-03-31", "filed": "2026-05-07", "value": -100451000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2026-05-07", "value": 219790000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-10-01", "end": "2025-12-31", "filed": "2026-02-05", "value": 40809000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2025Q4" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2026-02-05", "value": -161412000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2024Q4" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-10-01", "end": "2025-09-30", "filed": "2025-11-25", "value": 98346000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2025-11-25", "value": -601080000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2022-10-01", "end": "2023-09-30", "filed": "2025-11-25", "value": -205002000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2025-08-07", "value": 54240000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2023-10-01", "end": "2024-06-30", "filed": "2025-08-07", "value": -438877000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2025-05-12", "value": 219790000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2023-10-01", "end": "2024-03-31", "filed": "2025-05-12", "value": -262736000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2025-02-10", "value": -161412000, "unit": "USD", "accession": "0001628280-25-004634", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2023-10-01", "end": "2023-12-31", "filed": "2025-02-10", "value": -136545000, "unit": "USD", "accession": "0001628280-25-004634", "frame": "CY2023Q4" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2024-11-26", "value": -601080000, "unit": "USD", "accession": "0001628280-24-049277", "frame": null } ] }, { "label": "Nettoresultat", "taxonomy": "us-gaap", "concept": "NetIncomeLoss", "description": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label_original": "Net Income (Loss) Attributable to Parent", "facts": [ { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2025-10-01", "end": "2026-06-30", "filed": "2026-08-04", "value": -296205000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2026-08-04", "value": 22119000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2025-10-01", "end": "2026-03-31", "filed": "2026-05-07", "value": -101919000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2026-05-07", "value": 197360000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-10-01", "end": "2025-12-31", "filed": "2026-02-05", "value": 30811000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2025Q4" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2026-02-05", "value": -173085000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2024Q4" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-10-01", "end": "2025-09-30", "filed": "2025-11-25", "value": -1631000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2025-11-25", "value": -599493000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2022-10-01", "end": "2023-09-30", "filed": "2025-11-25", "value": -205275000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2025-08-07", "value": 22119000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2023-10-01", "end": "2024-06-30", "filed": "2025-08-07", "value": -428957000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2025-05-12", "value": 197360000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2023-10-01", "end": "2024-03-31", "filed": "2025-05-12", "value": -258164000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2025-02-10", "value": -173085000, "unit": "USD", "accession": "0001628280-25-004634", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2023-10-01", "end": "2023-12-31", "filed": "2025-02-10", "value": -132864000, "unit": "USD", "accession": "0001628280-25-004634", "frame": "CY2023Q4" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2024-11-26", "value": -599493000, "unit": "USD", "accession": "0001628280-24-049277", "frame": null } ] }, { "label": "Resultat per aktie, utspätt", "taxonomy": "us-gaap", "concept": "EarningsPerShareDiluted", "description": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label_original": "Earnings Per Share, Diluted", "facts": [ { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2025-10-01", "end": "2026-06-30", "filed": "2026-08-04", "value": -2.1, "unit": "USD/shares", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2026-08-04", "value": 0.17, "unit": "USD/shares", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2025-10-01", "end": "2026-03-31", "filed": "2026-05-07", "value": -0.73, "unit": "USD/shares", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2026-05-07", "value": 1.52, "unit": "USD/shares", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-10-01", "end": "2025-12-31", "filed": "2026-02-05", "value": 0.22, "unit": "USD/shares", "accession": "0000879407-26-000034", "frame": "CY2025Q4" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2026-02-05", "value": -1.39, "unit": "USD/shares", "accession": "0000879407-26-000034", "frame": "CY2024Q4" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-10-01", "end": "2025-09-30", "filed": "2025-11-25", "value": -0.01, "unit": "USD/shares", "accession": "0000879407-25-000029", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2025-11-25", "value": -5, "unit": "USD/shares", "accession": "0000879407-25-000029", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2022-10-01", "end": "2023-09-30", "filed": "2025-11-25", "value": -1.92, "unit": "USD/shares", "accession": "0000879407-25-000029", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2025-08-07", "value": 0.17, "unit": "USD/shares", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2023-10-01", "end": "2024-06-30", "filed": "2025-08-07", "value": -3.63, "unit": "USD/shares", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2025-05-12", "value": 1.52, "unit": "USD/shares", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2023-10-01", "end": "2024-03-31", "filed": "2025-05-12", "value": -2.24, "unit": "USD/shares", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2025-02-10", "value": -1.39, "unit": "USD/shares", "accession": "0001628280-25-004634", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2023-10-01", "end": "2023-12-31", "filed": "2025-02-10", "value": -1.24, "unit": "USD/shares", "accession": "0001628280-25-004634", "frame": "CY2023Q4" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2024-11-26", "value": -5, "unit": "USD/shares", "accession": "0001628280-24-049277", "frame": null } ] }, { "label": "Kassa", "taxonomy": "us-gaap", "concept": "CashAndCashEquivalentsAtCarryingValue", "description": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label_original": "Cash and Cash Equivalents, at Carrying Value", "facts": [ { "fy": 2024, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-06-30", "filed": "2024-08-08", "value": 69400000, "unit": "USD", "accession": "0001628280-24-036104", "frame": "CY2024Q2I" }, { "fy": 2024, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-03-31", "filed": "2024-05-09", "value": 127700000, "unit": "USD", "accession": "0001628280-24-022215", "frame": "CY2024Q1I" }, { "fy": 2024, "fp": "Q1", "form": "10-Q", "start": null, "end": "2023-12-31", "filed": "2024-02-06", "value": 58200000, "unit": "USD", "accession": "0001628280-24-003492", "frame": "CY2023Q4I" }, { "fy": 2023, "fp": "Q3", "form": "10-Q", "start": null, "end": "2023-06-30", "filed": "2023-08-07", "value": 105300000, "unit": "USD", "accession": "0001628280-23-027771", "frame": "CY2023Q2I" }, { "fy": 2023, "fp": "Q2", "form": "10-Q", "start": null, "end": "2023-03-31", "filed": "2023-05-02", "value": 135000000, "unit": "USD", "accession": "0001628280-23-014856", "frame": "CY2023Q1I" }, { "fy": 2023, "fp": "Q1", "form": "10-Q", "start": null, "end": "2022-12-31", "filed": "2023-02-06", "value": 202200000, "unit": "USD", "accession": "0001628280-23-002413", "frame": "CY2022Q4I" }, { "fy": 2022, "fp": "Q3", "form": "10-Q", "start": null, "end": "2022-06-30", "filed": "2022-08-04", "value": 139439000, "unit": "USD", "accession": "0001628280-22-021068", "frame": "CY2022Q2I" }, { "fy": 2022, "fp": "Q3", "form": "10-Q", "start": null, "end": "2021-09-30", "filed": "2022-08-04", "value": 184434000, "unit": "USD", "accession": "0001628280-22-021068", "frame": "CY2021Q3I" }, { "fy": 2022, "fp": "Q2", "form": "10-Q", "start": null, "end": "2022-03-31", "filed": "2022-05-10", "value": 86408000, "unit": "USD", "accession": "0001564590-22-019275", "frame": "CY2022Q1I" }, { "fy": 2022, "fp": "Q2", "form": "10-Q", "start": null, "end": "2021-09-30", "filed": "2022-05-10", "value": 184434000, "unit": "USD", "accession": "0001564590-22-019275", "frame": null }, { "fy": 2022, "fp": "Q1", "form": "10-Q", "start": null, "end": "2021-12-31", "filed": "2022-02-02", "value": 91587000, "unit": "USD", "accession": "0001564590-22-003616", "frame": "CY2021Q4I" }, { "fy": 2022, "fp": "Q1", "form": "10-Q", "start": null, "end": "2021-09-30", "filed": "2022-02-02", "value": 184434000, "unit": "USD", "accession": "0001564590-22-003616", "frame": null }, { "fy": 2021, "fp": "FY", "form": "10-K", "start": null, "end": "2021-09-30", "filed": "2021-11-22", "value": 184434000, "unit": "USD", "accession": "0001564590-21-057888", "frame": null }, { "fy": 2021, "fp": "FY", "form": "10-K", "start": null, "end": "2020-09-30", "filed": "2021-11-22", "value": 143583000, "unit": "USD", "accession": "0001564590-21-057888", "frame": "CY2020Q3I" }, { "fy": 2021, "fp": "Q3", "form": "10-Q", "start": null, "end": "2021-06-30", "filed": "2021-08-05", "value": 325981000, "unit": "USD", "accession": "0001564590-21-041593", "frame": "CY2021Q2I" }, { "fy": 2021, "fp": "Q3", "form": "10-Q", "start": null, "end": "2020-09-30", "filed": "2021-08-05", "value": 143583000, "unit": "USD", "accession": "0001564590-21-041593", "frame": null } ] }, { "label": "Tillgångar", "taxonomy": "us-gaap", "concept": "Assets", "description": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label_original": "Assets", "facts": [ { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": null, "end": "2026-06-30", "filed": "2026-08-04", "value": 2112013000, "unit": "USD", "accession": "0000879407-26-000057", "frame": "CY2026Q2I" }, { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2026-08-04", "value": 1385295000, "unit": "USD", "accession": "0000879407-26-000057", "frame": "CY2025Q3I" }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": null, "end": "2026-03-31", "filed": "2026-05-07", "value": 2268265000, "unit": "USD", "accession": "0000879407-26-000047", "frame": "CY2026Q1I" }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2026-05-07", "value": 1385295000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-12-31", "filed": "2026-02-05", "value": 1604181000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2025Q4I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2026-02-05", "value": 1385295000, "unit": "USD", "accession": "0000879407-26-000034", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2025-09-30", "filed": "2025-11-25", "value": 1385295000, "unit": "USD", "accession": "0000879407-25-000029", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2024-09-30", "filed": "2025-11-25", "value": 1139802000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2024Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-08-07", "value": 1380612000, "unit": "USD", "accession": "0001628280-25-038858", "frame": "CY2025Q2I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2025-08-07", "value": 1139802000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2025-05-12", "value": 1573498000, "unit": "USD", "accession": "0001628280-25-024666", "frame": "CY2025Q1I" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2025-05-12", "value": 1139802000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-02-10", "value": 1013694000, "unit": "USD", "accession": "0001628280-25-004634", "frame": "CY2024Q4I" }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2025-02-10", "value": 1139802000, "unit": "USD", "accession": "0001628280-25-004634", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2024-09-30", "filed": "2024-11-26", "value": 1139802000, "unit": "USD", "accession": "0001628280-24-049277", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2023-09-30", "filed": "2024-11-26", "value": 765552000, "unit": "USD", "accession": "0001628280-24-049277", "frame": "CY2023Q3I" } ] }, { "label": "Eget kapital", "taxonomy": "us-gaap", "concept": "StockholdersEquity", "description": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label_original": "Stockholders' Equity Attributable to Parent", "facts": [ { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": null, "end": "2026-06-30", "filed": "2026-08-04", "value": 465529000, "unit": "USD", "accession": "0000879407-26-000057", "frame": "CY2026Q2I" }, { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2026-08-04", "value": 466052000, "unit": "USD", "accession": "0000879407-26-000057", "frame": "CY2025Q3I" }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": null, "end": "2026-03-31", "filed": "2026-05-07", "value": 613977000, "unit": "USD", "accession": "0000879407-26-000047", "frame": "CY2026Q1I" }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2026-05-07", "value": 466052000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-12-31", "filed": "2026-02-05", "value": 568422000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2025Q4I" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": null, "end": "2025-09-30", "filed": "2026-02-05", "value": 466052000, "unit": "USD", "accession": "0000879407-26-000034", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2025-09-30", "filed": "2025-11-25", "value": 466052000, "unit": "USD", "accession": "0000879407-25-000029", "frame": null }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": null, "end": "2024-09-30", "filed": "2025-11-25", "value": 185444000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2024Q3I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2025-06-30", "filed": "2025-08-07", "value": 522313000, "unit": "USD", "accession": "0001628280-25-038858", "frame": "CY2025Q2I" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2025-08-07", "value": 185444000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2025-03-31", "filed": "2025-05-12", "value": 683321000, "unit": "USD", "accession": "0001628280-25-024666", "frame": "CY2025Q1I" }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2025-05-12", "value": 185444000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-12-31", "filed": "2025-02-10", "value": 52589000, "unit": "USD", "accession": "0001628280-25-004634", "frame": "CY2024Q4I" }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": null, "end": "2024-09-30", "filed": "2025-02-10", "value": 185444000, "unit": "USD", "accession": "0001628280-25-004634", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2024-09-30", "filed": "2024-11-26", "value": 185444000, "unit": "USD", "accession": "0001628280-24-049277", "frame": null }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": null, "end": "2023-09-30", "filed": "2024-11-26", "value": 271343000, "unit": "USD", "accession": "0001628280-24-049277", "frame": "CY2023Q3I" } ] }, { "label": "Operativt kassaflöde", "taxonomy": "us-gaap", "concept": "NetCashProvidedByUsedInOperatingActivities", "description": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label_original": "Net Cash Provided by (Used in) Operating Activities", "facts": [ { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2025-10-01", "end": "2026-06-30", "filed": "2026-08-04", "value": -79546000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2026-08-04", "value": 159061000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2025-10-01", "end": "2026-03-31", "filed": "2026-05-07", "value": 97923000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2026-05-07", "value": 313781000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-10-01", "end": "2025-12-31", "filed": "2026-02-05", "value": 13481000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2025Q4" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2026-02-05", "value": -146272000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2024Q4" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-10-01", "end": "2025-09-30", "filed": "2025-11-25", "value": 179552000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2025-11-25", "value": -462851000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2022-10-01", "end": "2023-09-30", "filed": "2025-11-25", "value": -153890000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2025-08-07", "value": 159061000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2023-10-01", "end": "2024-06-30", "filed": "2025-08-07", "value": -325635000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2025-05-12", "value": 313781000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2023-10-01", "end": "2024-03-31", "filed": "2025-05-12", "value": -210217000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2025-02-10", "value": -146272000, "unit": "USD", "accession": "0001628280-25-004634", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2023-10-01", "end": "2023-12-31", "filed": "2025-02-10", "value": -117840000, "unit": "USD", "accession": "0001628280-25-004634", "frame": "CY2023Q4" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2024-11-26", "value": -462851000, "unit": "USD", "accession": "0001628280-24-049277", "frame": null } ] }, { "label": "Investeringar", "taxonomy": "us-gaap", "concept": "PaymentsToAcquirePropertyPlantAndEquipment", "description": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label_original": "Payments to Acquire Property, Plant, and Equipment", "facts": [ { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2025-10-01", "end": "2026-06-30", "filed": "2026-08-04", "value": 8567000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2026-08-04", "value": 15177000, "unit": "USD", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2025-10-01", "end": "2026-03-31", "filed": "2026-05-07", "value": 4713000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2026-05-07", "value": 12813000, "unit": "USD", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-10-01", "end": "2025-12-31", "filed": "2026-02-05", "value": 2148000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2025Q4" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2026-02-05", "value": 7516000, "unit": "USD", "accession": "0000879407-26-000034", "frame": "CY2024Q4" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-10-01", "end": "2025-09-30", "filed": "2025-11-25", "value": 22666000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2025-11-25", "value": 141469000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2022-10-01", "end": "2023-09-30", "filed": "2025-11-25", "value": 176737000, "unit": "USD", "accession": "0000879407-25-000029", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2025-08-07", "value": 15177000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2023-10-01", "end": "2024-06-30", "filed": "2025-08-07", "value": 117180000, "unit": "USD", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2025-05-12", "value": 12813000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2023-10-01", "end": "2024-03-31", "filed": "2025-05-12", "value": 102731000, "unit": "USD", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2025-02-10", "value": 7516000, "unit": "USD", "accession": "0001628280-25-004634", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2023-10-01", "end": "2023-12-31", "filed": "2025-02-10", "value": 68656000, "unit": "USD", "accession": "0001628280-25-004634", "frame": "CY2023Q4" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2024-11-26", "value": 141469000, "unit": "USD", "accession": "0001628280-24-049277", "frame": null } ] }, { "label": "Antal aktier, utspätt", "taxonomy": "us-gaap", "concept": "WeightedAverageNumberOfDilutedSharesOutstanding", "description": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label_original": "Weighted Average Number of Shares Outstanding, Diluted", "facts": [ { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2025-10-01", "end": "2026-06-30", "filed": "2026-08-04", "value": 141331000, "unit": "shares", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2026-08-04", "value": 133352000, "unit": "shares", "accession": "0000879407-26-000057", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2025-10-01", "end": "2026-03-31", "filed": "2026-05-07", "value": 139762000, "unit": "shares", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2026-05-07", "value": 130265000, "unit": "shares", "accession": "0000879407-26-000047", "frame": null }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2025-10-01", "end": "2025-12-31", "filed": "2026-02-05", "value": 140706000, "unit": "shares", "accession": "0000879407-26-000034", "frame": "CY2025Q4" }, { "fy": 2026, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2026-02-05", "value": 124848000, "unit": "shares", "accession": "0000879407-26-000034", "frame": "CY2024Q4" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2024-10-01", "end": "2025-09-30", "filed": "2025-11-25", "value": 133758000, "unit": "shares", "accession": "0000879407-25-000029", "frame": "CY2025" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2025-11-25", "value": 119784000, "unit": "shares", "accession": "0000879407-25-000029", "frame": "CY2024" }, { "fy": 2025, "fp": "FY", "form": "10-K", "start": "2022-10-01", "end": "2023-09-30", "filed": "2025-11-25", "value": 106750000, "unit": "shares", "accession": "0000879407-25-000029", "frame": "CY2023" }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2024-10-01", "end": "2025-06-30", "filed": "2025-08-07", "value": 133352000, "unit": "shares", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q3", "form": "10-Q", "start": "2023-10-01", "end": "2024-06-30", "filed": "2025-08-07", "value": 118260000, "unit": "shares", "accession": "0001628280-25-038858", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2024-10-01", "end": "2025-03-31", "filed": "2025-05-12", "value": 130265000, "unit": "shares", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q2", "form": "10-Q", "start": "2023-10-01", "end": "2024-03-31", "filed": "2025-05-12", "value": 115307000, "unit": "shares", "accession": "0001628280-25-024666", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2024-10-01", "end": "2024-12-31", "filed": "2025-02-10", "value": 124848000, "unit": "shares", "accession": "0001628280-25-004634", "frame": null }, { "fy": 2025, "fp": "Q1", "form": "10-Q", "start": "2023-10-01", "end": "2023-12-31", "filed": "2025-02-10", "value": 107415000, "unit": "shares", "accession": "0001628280-25-004634", "frame": "CY2023Q4" }, { "fy": 2024, "fp": "FY", "form": "10-K", "start": "2023-10-01", "end": "2024-09-30", "filed": "2024-11-26", "value": 119784000, "unit": "shares", "accession": "0001628280-24-049277", "frame": null } ] } ] }, "morningstar": { "configured": false, "status": "inte hämtad", "captured_at": null, "view_count": 0, "url": "/company/arrowhead-pharmaceuticals-inc/morningstar" }, "finansinspektionen": { "available": false, "status": "skipped", "url": "/company/arrowhead-pharmaceuticals-inc/finansinspektionen", "transaction_count": 0, "aggregate_short_percent": null, "files": [] }, "llms_url": "/company/arrowhead-pharmaceuticals-inc/llms.txt", "json_url": "/company/arrowhead-pharmaceuticals-inc/company.json", "document_index_url": "/company/arrowhead-pharmaceuticals-inc/documents.json", "absolute_url": "https://spela.port0.org/company/arrowhead-pharmaceuticals-inc" }